Management of Mild COPD Exacerbations

Initial Assessment and Management

The British Thoracic Society recommends increasing bronchodilator therapy first, adding or increasing beta-agonists and/or anticholinergics before considering corticosteroids, and ensuring the patient can use their inhaler device effectively 1, 2
Nebulizers are usually not required for mild exacerbations, according to the British Thoracic Society 1

The British Thoracic Society guidelines state that oral corticosteroids should be withheld in community-managed mild exacerbations unless the patient is already taking maintenance oral corticosteroids, has previously documented response to oral corticosteroids, airflow obstruction fails to respond to increased bronchodilator dosing, or it is the first presentation of airflow obstruction 1
The European Respiratory Society suggests considering a short course of corticosteroids if marked wheeze is present 2

If corticosteroids are prescribed, the recommended dose is prednisolone 30 mg daily for 5-7 days, as this duration is as effective as 14 days with fewer adverse effects and reduced glucocorticoid exposure 4, 3

Systemic corticosteroids provide reduced treatment failure, lower relapse rate, improved lung function, and shorter hospital stay, although these benefits are based on studies of moderate-to-severe exacerbations 5, 3

Corticosteroids increase adverse events, including hyperglycemia, weight gain, fluid retention, insomnia, and mood changes, particularly in patients with diabetes 3

A blood eosinophil count ≥2% predicts better response to corticosteroids, although current guidelines recommend treatment for all exacerbations regardless of eosinophil levels when corticosteroids are indicated 4, 3

The British Thoracic Society recommends never using the oral route if unavailable, and instead using IV hydrocortisone 100 mg, and never extending corticosteroid treatment beyond 5-7 days for acute exacerbations 6, 4, 3

After any exacerbation, the patient should be reviewed within 48 hours if managed at home, and inhaled corticosteroid/long-acting beta-agonist combination therapy should be optimized to prevent future exacerbations 1, 5, 3